Cargando…
Preparation and Bioactivity Assessment of Chitosan-1-Acetic Acid-5-Flurouracil Conjugates as Cancer Prodrugs
5-fluorouracil (5-FU) is a specific anti-cancer agent that is generally used to treat gastrointestinal, colorectal, and breast cancer. In this work, chitosan (CS) was extracted from local fish scales using an established method. 5-FU was then converted to 1-acetic acid-5-fluorouracil (FUAC) and reac...
Autores principales: | Mohammed, Mohsin O., Hussain, Kameran S., Haj, Nadia Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150397/ https://www.ncbi.nlm.nih.gov/pubmed/29117097 http://dx.doi.org/10.3390/molecules22111629 |
Ejemplares similares
-
A new prodrug and bioactivity evaluation of methotrexate based on Chitosan
por: Mohammed, Mohsin Omar, et al.
Publicado: (2020) -
Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats
por: El-Sayyad, Hassan I, et al.
Publicado: (2009) -
Current Developments in Pt(IV) Prodrugs Conjugated with Bioactive Ligands
por: Li, Xuejiao, et al.
Publicado: (2018) -
Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer
por: Yassin, Alaa Eldeen B., et al.
Publicado: (2010) -
Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis
por: Lee, Jung Min, et al.
Publicado: (2019)